These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16468316)

  • 1. [The inhibiting effect of polygoni multiflori total glycosides (PMTG) on the atherosclerotic lesion formation in experimental atherosclerosis].
    Fang W; Zhang HX; Wang LY; Wu Y; Qin YW; Wang W; Du LP; Liu B
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):600-1. PubMed ID: 16468316
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of polygoni multiflori total glycosides on the experimentally atherosclerotic formation in apoE-deficient mice].
    Fang W; Zhang HX; Wang LY; Wu Y; Qin YW; Wang W; Du LP; Lu B
    Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(19):1542-5. PubMed ID: 16335829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of PMTG on atherosclerotic lesion formation and expression of ICAM-1 and VCAM-1 in ApoE-deficient mice].
    Fang W; Zhang HX; Wang LY; Qin YW; Wu Y; Wang W; Liu B
    Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(13):1320-3. PubMed ID: 17879736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dealcoholised beers reduce atherosclerosis and expression of adhesion molecules in apoE-deficient mice.
    Martinez N; Urpi-Sarda M; Martinez-Gonzalez MA; Andres-Lacueva C; Mitjavila MT
    Br J Nutr; 2011 Mar; 105(5):721-30. PubMed ID: 21134332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A; Zhao Y; Warren JS
    Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
    Jacob S; Laury-Kleintop L; Lanza-Jacoby S
    J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation.
    Wei HJ; Li YH; Shi GY; Liu SL; Chang PC; Kuo CH; Wu HL
    Cardiovasc Res; 2011 Nov; 92(2):317-27. PubMed ID: 21840881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.
    Monetti M; Canavesi M; Camera M; Parente R; Paoletti R; Tremoli E; Corsini A; Bellosta S
    Pharmacol Res; 2007 May; 55(5):441-9. PubMed ID: 17350858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL/6J and atherosclerosis-prone ApoE(-/-) mice.
    Hoving S; Heeneman S; Gijbels MJ; Te Poele JA; Visser N; Cleutjens J; Russell NS; Daemen MJ; Stewart FA
    Radiother Oncol; 2012 Dec; 105(3):365-70. PubMed ID: 23245647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice.
    Noh JR; Lee IK; Kim YH; Gang GT; Hwang JH; Ly SY; Yun BS; Lee CH
    Ann Nutr Metab; 2011; 59(2-4):145-53. PubMed ID: 22142871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
    Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
    Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
    Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
    Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice.
    Matsumoto M; Sata M; Fukuda D; Tanaka K; Soma M; Hirata Y; Nagai R
    Atherosclerosis; 2008 Apr; 197(2):524-33. PubMed ID: 17765904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on purification of 2,3,5,4'-tetrahydroxy-stilbene-2-O-beta-D-glycoside from Polygonum multiflori].
    Jiang TT; Ouyang Z; Miao YD; Zhang XF
    Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):646-9. PubMed ID: 16830821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of content of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside and anthraquinon in different ploidy Radix Polygoni Multiflori].
    Jiao XW; Zhang XN; Zhao X; Yan P; Zhao SJ
    Zhong Yao Cai; 2007 Dec; 30(12):1487-9. PubMed ID: 18422177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.
    Nachtigal P; Jamborova G; Pospisilova N; Pospechova K; Solichova D; Zdansky P; Semecky V
    J Pharm Pharm Sci; 2006; 9(2):222-30. PubMed ID: 16959191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.
    Møller F; Andersen CB; Nielsen LB
    Scand J Clin Lab Invest; 2005; 65(7):559-70. PubMed ID: 16271987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
    Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.